Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by VarmX

VarmX Partners With CSL in a Strategic Collaboration and Option Agreement to Develop Novel Investigational Coagulation Treatment
From VarmX
Via Business Wire
VarmX Announces Appointment of John Glasspool as CEO
From VarmX
Via Business Wire
VarmX to Attend LSX World Congress and Bio€quity Europe in Q2 2024
From VarmX
Via Business Wire
VarmX Promotes CSO Dr. Jeffrey Lawson to New CEO and Moves to New State-of-the-Art Facility
From VarmX
Via Business Wire
VarmX Raises €30 Million Series B2 Financing for IND Approval and Preparations for Pivotal Trial
From VarmX
Via Business Wire
VarmX Appoints Dr. Jeffrey Lawson, MD, PhD as Chief Scientific Officer
From VarmX
Via Business Wire
First Subjects Dosed in First-in-Human Trial for VarmX’s Anticoagulant Reversal Agent, VMX-C001
From VarmX
Via Business Wire
VarmX Awarded Funding From the EIC Accelerator to Support Scale up and Manufacturing of VMX-C001
From VarmX
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.